Original Research
Accepted on 09 Oct 2025
Phase 2 Trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcoma
in Cancer Immunity and Immunotherapy
- 108 views